The perennial allergic rhinitis market is projected to progress steadily, supported by a relatively small but focused pipeline of emerging therapies. Companies developing candidates such as EBGLYSS ...
The guidelines focus on three key clinical statements. The American College of Allergy, Asthma, and Immunology (ACAAI) has issued updated guidelines on the treatment of seasonal allergic rhinitis (SAR ...
An update of recommendations for the treatment of seasonal allergic rhinitis (SAR) in adolescents and adults, issued by members of the Joint Task Force on Practice Parameters (JTFPP), changes initial ...
For patients with allergic rhinitis whose symptoms aren't helped by one treatment, adding another may work, according to results of a systematic review and meta-analysis published in a recent issue of ...
In A Nutshell Mice with allergic rhinitis sneezed significantly less after receiving matcha extract in a new study from ...
Experimental research suggests matcha tea may reduce sneezing in allergic rhinitis by suppressing neuronal activation ...
The "Allergic Rhinitis Market- A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The global ...
Biopharmaceutical company Allovate has signed an agreement with personalized medicine firm Restore Health for the exclusive rights to provide Allerdent, a new therapeutic toothpaste delivery system ...
Recent developments in allergen immunotherapy, improvements in primary care, and the emergence of a new treatment for other allergic conditions have improved the quality of care for seasonal allergies ...
DUBLIN--(BUSINESS WIRE)--The "Global Allergic Rhinitis Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering. The research provides insights into ...
Everyday Health on MSN
Psoriasis and allergies: What’s the connection?
Learn how psoriasis, allergies, and eczema are connected and how they're different. Get lifestyle tips on managing both.
(MENAFN- GlobeNewsWire - Nasdaq) The perennial allergic rhinitis market is projected to progress steadily, supported by a relatively small but focused pipeline of emerging therapies. Companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results